Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

SSRI use in late pregnancy linked to newborn pulmonary hypertension

Infants whose mothers took selective serotonin reuptake inhibitors (SSRIs) in late pregnancy may be at increased risk of persistent pulmonary hypertension of the newborn (BMJ online, 14 January 2014).

A meta-analysis of seven studies, carried out by Canadian researchers, showed an increased risk (odds ratio 2.50, 95 per cent confidence interval 1.32–4.73; P=0.005). However, although the results are statistically significant, the researchers say that the low incidence of persistent pulmonary hypertension of the newborn in the general population (around two cases/1,000 live births) means that the absolute risk as a result of SSRI exposure remains low. They estimate that 286 to 351 women would need to be treated with an SSRI in late pregnancy for one additional case to be seen.

Data were not available for assessing the contribution of other risk factors, which include premature birth, maternal obesity and caesarian section. There was no increased risk associated with maternal use of SSRIs in early pregnancy.

The researchers had planned to look at all antidepressants but there was a lack of data on drug classes other than SSRIs.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.11132974

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Baby in incubator (Paul Brain/

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.